Biogen Idec Inc. disclosed in its latest quarterly report on Form 10-Q filed with the U.S. Securities and Exchange Commission that it is cooperating with the U.S. Department of Justice in its investigation of Genentech related to the promotion of…
The complaint filed against Dr. Henry Samueli and three other former executive officers is still ongoing, Broadcom Corp. disclosed in its latest quarterly report on Form 10-Q filed with the U.S. Securities and Exchange Commission.
In May 2008, the SEC filed…
Broadcom Corp.’s special litigation committee, the SLC, is currently reviewing the course of action the Company should pursue in respect of the claims asserted in the Options Derivative Actions.
From March through August 2006, a number of purported Broadcom shareholders filed…
Broadcom Corp. disclosed in its latest quarterly report on Form 10-Q filed with the U.S. Securities and Exchange Commission that Randy Lee Soderstrom has filed a notice of appeal on the dismissal of of his First Amended Complaint by the…
Mediation on outstanding claims filed against Biogen Idec Inc. and its subsidiary Biogen Inc. (n/k/a Biogen Idec MA Inc.) over certain drugs for which Medicaid provides reimbursement (covered drugs) is still ongoing, The Company disclosed in its latest quarterly report…
Broadcom Corp. disclosed in its latest quarterly report on Form 10-Q filed with the U.S. Securities and Exchange Commission that in June 2009, the company dismissed its complaint against Emulex Corp. in Delaware Chancery Court.
In April 2009, the company filed…
Biogen Idec Inc. disclosed in its latest quarterly report on Form 10-Q filed with the U.S. Securities and Exchange Commission that on June 15, 2009, a panel issued its final decision in the arbitration filed by the Company against Genentech,Inc.…
Biogen Idec Inc. disclosed in its latest quarterly report on Form 10-Q filed with the U.S. Securities and Exchange Commission that the European Commission, or the EC, published its final report on an inquiry in July 2009 in which it…
Broadcom Corp. continues to cooperate with the U.S. Attorney’s Office for the Central District of California relating to alleged stock options backdating, the company disclosed in its latest quarterly report on Form 10-Q filed with the U.S. Securities and Exchange…
Halliburton Co. disclosed in its latest quarterly report on Form 10-Q filed with the U.S. Securities and Exchange Commission that two shareholder derivative lawsuits in Texas are ongoing.
In May 2009, two shareholder derivative lawsuits involving the company and KBR were…